November 2022 Unlocking the Clinical and Economic Value of FibroScan®: Strategies for Optimizing Utilization and Reimbursement in Practice
November 2022 Understanding New FibroScan® Software Enhancements Which Optimize Overweight Patient Testing
May 2022 Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment
March 2022 Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective
FibroScan®
